Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 625.00 | 354.63 | 604.00 | 650.00 | 0.9292 | 0.8389 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 625.00 | 354.63 | 364.00 | 650.00 | 0.5600 | 0.0303 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 625.00 | 354.63 | 603.00 | 650.00 | 0.9277 | 0.8354 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 625.00 | 354.63 | 397.00 | 650.00 | 0.6108 | 0.1378 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 625.00 | 354.63 | 623.00 | 650.00 | 0.9585 | 0.9053 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 800.00 | 650.00 | 1.2308 | 1.5362 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 633.00 | 650.00 | 0.9739 | 0.9403 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 623.00 | 650.00 | 0.9585 | 0.9053 | |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 625.00 | 354.63 | 743.00 | 650.00 | 1.1431 | 1.3306 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 606.00 | 650.00 | 0.9323 | 0.8459 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 625.00 | 354.63 | 468.00 | 650.00 | 0.7200 | 0.3735 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 625.00 | 354.63 | 463.00 | 650.00 | 0.7123 | 0.3567 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 625.00 | 354.63 | 387.00 | 650.00 | 0.5954 | 0.1051 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 354.63 | 609.00 | 650.00 | 0.9369 | 0.8564 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 693.00 | 650.00 | 1.0662 | 1.1521 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 625.00 | 354.63 | 323.00 | 650.00 | 0.4969 | -0.1014 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 689.00 | 650.00 | 1.0600 | 1.1379 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 6.00 | 650.00 | 0.0092 | -0.9906 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 2.00 | 650.00 | 0.0031 | -0.9973 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 574.00 | 650.00 | 0.8831 | 0.7348 | |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 625.00 | 354.63 | 344.00 | 650.00 | 0.5292 | -0.0342 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 625.00 | 354.63 | 744.00 | 650.00 | 1.1446 | 1.3342 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 814.00 | 650.00 | 1.2523 | 1.5871 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 625.00 | 354.63 | 877.00 | 650.00 | 1.3492 | 1.8174 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 764.00 | 650.00 | 1.1754 | 1.4061 |